Comparison Overview
Cipla

Cipla
Lower Parel, Ganpatrao Kadam Marg,, Mumbai, Maharashtra, IN, 400013
Last Update: 01/04/2026
Cipla is a leading global pharmaceutical company trusted by healthcare professionals and patients across the world since 1935. A compassionate approach to healthcare that goes beyond the pursuit of profit and growth has been the force impelling Cipla’s history over the ...

Astellas Pharma
N/A
Last Update: 07/09/2026
Astellas is a global life sciences company committed to turning innovative science into VALUE for patients. We provide transformative therapies in disease areas that include oncology, ophthalmology, urology, immunology and women's health. Through our research and develo...
Compliance Ranges Comparison

Cipla







Astellas Pharma






Benchmark & Cyber Underwriting Signals
Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)
No incidents recorded for Cipla in 2026.
Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)
No incidents recorded for Astellas Pharma in 2026.
Incident History - Cipla (X = Date, Y = Severity)
Cipla cyber incidents detection timeline including parent company and subsidiaries.
Incident History - Astellas Pharma (X = Date, Y = Severity)
Astellas Pharma cyber incidents detection timeline including parent company and subsidiaries.
Notable Incidents

Cipla

Astellas Pharma
FAQ
Latest Global CVEs
Netskope was notified about a potential gap in Netskope Endpoint DLP (EPDLP) running on Windows systems. Successful exploitation of the gap could potentially allow a privileged user to send a crafted message to the EPDLP process port to trigger an integer overflow, leading to memory corruption. Successful exploitation would require the EPDLP module to be enabled in the client configuration, and that Memory Integrity is disabled. A successful exploit could potentially result in a denial-of-service, arbitrary code execution, or privilege escalation on the local machine.
Netskope was notified of an out-of-bounds heap read affecting the Endpoint DLP (EPDLP) service of the Netskope Client. A local standard user could potentially send a specially crafted message that is not properly validated with a bounds check, likely crashing the kernel driver handler. Successful exploitation could potentially crash the EPDLP service, temporarily interrupting DLP enforcement. A successful exploit could potentially also reveal per-boot memory layout information to unauthorized users.
IBM Db2 11.5.0 through 11.5.9, and 12.1.0 through 12.1.5 is vulnerable to a denial of service where a specific functionality on a Db2 server can be disabled by a privileged user under certain conditions.
IBM Db2 11.5.0 through 11.5.9, and 12.1.0 through 12.1.5 could allow an attacker with the ability to control or impersonate a DRDA server endpoint to execute arbitrary commands on Db2 clients due to a stack-based buffer overflow that improperly copies user-controlled data into a fixed-size stack buffer without bounds checking.
IBM Db2 11.5.0 through 11.5.9, and 12.1.0 through 12.1.5 could allow an authenticated user to send a specially crafted request to write arbitrary files on the system.